Retour
Fourchette du Jour
1,11 €
1,16 €
Fourchette 52 Semaines
1,10 €
1,83 €
Volume
4 402 822
Moyenne 50J / 200J
1,24 €
/
1,34 €
Clôture Précédente
1,12 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,9 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | -17,1 | 3,7 |
| Net Margin % | -37,2 | 3,9 |
| Rev Growth 5Y % | -23,5 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
1,60 €
+39.1%
BPA Prévisionnel
-0,28 €
CA Est.
550 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,04 €
-0,04 € – -0,04 €
|
690 M | 1 |
| FY2029 |
-0,08 €
-0,08 € – -0,08 €
|
650 M | 1 |
| FY2028 |
-0,08 €
-0,16 € – 0,00 €
|
610 M | 3 |
Points Clés
Revenue declined -23,53% annually over 5 years
Debt/Equity of 0,34 — conservative balance sheet
Negative free cash flow of -190,82M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8,63%
Capital efficient — spends only 2,02% of revenue on capex
Croissance
Revenue Growth (5Y)
-23,53%
Revenue (1Y)-14,90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-17,14%
ROIC-9,65%
Net Margin-37,20%
Op. Margin-36,08%
Sécurité
Debt / Equity
0,34
Current Ratio3,97
Interest Coverage-2,16
Valorisation
P/E Ratio
-3,91
P/B Ratio0,70
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -14,90% | Revenue Growth (3Y) | -16,17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -23,53% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 606,88M | Net Income (TTM) | -225,73M |
| ROE | -17,14% | ROA | -11,68% |
| Gross Margin | 21,10% | Operating Margin | -36,08% |
| Net Margin | -37,20% | Free Cash Flow (TTM) | -190,82M |
| ROIC | -9,65% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,34 | Current Ratio | 3,97 |
| Interest Coverage | -2,16 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,91 | P/B Ratio | 0,70 |
| P/S Ratio | 1,45 | PEG Ratio | -0,02 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 882,86M | Enterprise Value | 947,38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 606,88M | 713,14M | 863,50M | 1,00B | 1,77B |
| Net Income | -225,73M | -53,22M | -188,86M | -328,41M | -30,14M |
| EPS (Diluted) | -0,30 | -0,08 | -0,25 | -0,46 | -0,05 |
| Gross Profit | 128,05M | 311,03M | 318,13M | 288,22M | 581,52M |
| Operating Income | -218,99M | -152,07M | -157,02M | -226,25M | 18,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,93B | 2,20B | 2,01B | 2,17B | 2,40B |
| Total Liabilities | 663,99M | 834,76M | 622,48M | 605,61M | 714,59M |
| Shareholders' Equity | 1,27B | 1,37B | 1,39B | 1,56B | 1,69B |
| Total Debt | 433,60M | 504,44M | 326,56M | 305,55M | 254,76M |
| Cash & Equivalents | 369,07M | 431,94M | 95,88M | 153,19M | 134,71M |
| Current Assets | 581,88M | 662,09M | 309,48M | 394,53M | 823,01M |
| Current Liabilities | 146,68M | 193,10M | 200,05M | 213,48M | 330,01M |